ShankerValleau Wealth Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$309K Hold
2,407
0.08% 32
2026
Q1
$290K Hold
2,407
0.08% 33
2025
Q4
$253K Hold
2,407
0.07% 35
2025
Q3
$202K Buy
+2,407
New +$198K 0.05% 41
2025
Q2
Sell
-2,407
Closed -$216K 42
2025
Q1
$216K Hold
2,407
0.07% 35
2024
Q4
$239K Buy
2,407
+300
+14% +$30.9K 0.08% 32
2024
Q3
$239K Hold
2,107
0.08% 26
2024
Q2
$261K Hold
2,107
0.11% 22
2024
Q1
$278K Hold
2,107
0.13% 20
2023
Q4
$230K Hold
2,107
0.12% 21
2023
Q3
$217K Hold
2,107
0.12% 21
2023
Q2
$243K Buy
+2,107
New +$239K 0.13% 20

Other funds holding MRK

ShankerValleau Wealth Advisors's MRK Position: Q2 2026 in Review

ShankerValleau Wealth Advisors held its Merck (MRK) position steady in Q2 2026 at 2,407 shares worth $309K. The position accounts for 0.08% of the portfolio, ranked #32.

ShankerValleau Wealth Advisors first reported a position in MRK in Q2 2023 and has held it in 12 quarters since. 1,153 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • ShankerValleau Wealth Advisors held 2,407 shares of Merck worth $309K as of Q2 2026.
  • ShankerValleau Wealth Advisors left its Merck share count unchanged in Q2 2026.
  • Merck made up 0.08% of ShankerValleau Wealth Advisors's portfolio in Q2 2026, its #32 holding.
  • ShankerValleau Wealth Advisors first reported a position in Merck in Q2 2023 and has held it in 12 quarters since.
  • 1,153 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on ShankerValleau Wealth Advisors's 13F filing for Q2 2026, filed 9 Jul 2026.